SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001854270-24-000122
Filing Date
2024-12-10
Accepted
2024-12-10 16:16:35
Documents
2
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1733865388.html 3  
1 FORM 3 wk-form3_1733865388.xml 3 1642
2 EX-24 fschulzpoa.txt EX-24 4603
  Complete submission text file 0001854270-24-000122.txt   7964
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SENTI BIOSCIENCES, INC. 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Schulz Fran (Reporting) CIK: 0002046804 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40440 | Film No.: 241538683